lactic acid has been researched along with rivaroxaban in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agnes Silva Camargo de Oliveira, A; Almada do Carmo, F; Cunha Sathler, P; de Souza Furtado, P; Mendes Cabral, L; Muniz da Paz, M; Pereira Rangel, L; Pinheiro da Costa, S; Raphaella Autran Colaço, A; Rita Santiago de Paula Gonçalves, A; Santiago Rodrigues, P; Simon, A; Wetler Meireles Carreiros Assumpção, P | 1 |
1 other study(ies) available for lactic acid and rivaroxaban
| Article | Year |
|---|---|
In vivo evaluation of time-dependent antithrombotic effect of rivaroxaban-loaded poly(lactic-co-glycolic acid)/sodium lauryl sulfate or didodecyl dimethylammonium bromide nanoparticles in Wistar rats.
Topics: Animals; Bromides; Fibrinolytic Agents; Glycols; Lactic Acid; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Rivaroxaban; Sodium Dodecyl Sulfate | 2023 |